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Abstract
Background: It has been postulated that genetic predisposition may influence the susceptibility to SARS-
coronavirus infection and disease outcomes. A recent study has suggested that the deletion allele (D allele) of the
angiotensin converting enzyme (ACE) gene is associated with hypoxemia in SARS patients. Moreover, the ACE D
allele has been shown to be more prevalent in patients suffering from adult respiratory distress syndrome (ARDS)
in a previous study. Thus, we have investigated the association between ACE insertion/deletion (I/D)
polymorphism and the progression to ARDS or requirement of intensive care in SARS patients.
Method: One hundred and forty genetically unrelated Chinese SARS patients and 326 healthy volunteers were
recruited. The ACE I/D genotypes were determined by polymerase chain reaction and agarose gel
electrophoresis.
Results: There is no significant difference in the genotypic distributions and the allelic frequencies of the ACE I/
D polymorphism between the SARS patients and the healthy control subjects. Moreover, there is also no evidence
that ACE I/D polymorphism is associated with the progression to ARDS or the requirement of intensive care in
the SARS patients. In multivariate logistic analysis, age is the only factor associated with the development of ARDS
while age and male sex are independent factors associated with the requirement of intensive care.
Conclusion: The ACE I/D polymorphism is not directly related to increased susceptibility to SARS-coronavirus
infection and is not associated with poor outcomes after SARS-coronavirus infection.
Published: 09 April 2005
BMC Infectious Diseases 2005, 5:26 doi:10.1186/1471-2334-5-26
Received: 11 January 2005
Accepted: 09 April 2005
This article is available from: http://www.biomedcentral.com/1471-2334/5/26
© 2005 Chan et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.BMC Infectious Diseases 2005, 5:26 http://www.biomedcentral.com/1471-2334/5/26
Page 2 of 6
(page number not for citation purposes)
Background
The outbreak of the severe acute respiratory syndrome
(SARS) has made a great impact to the health care systems
around the world. The pandemic affected over 8000 indi-
viduals and resulted in 774 deaths worldwide [1]. Several
clinical parameters, including male sex [2,3], age of over
60 years [2,3], elevated lactate dehydrogenase activity [2-
4], low platelet count [2] and high viral load on presenta-
tion [5], have been identified to be predictive of the sever-
ity of the disease in affected individuals. Moreover, it has
been postulated that genetic variations of the host and the
virus may account for the individual difference in the sus-
ceptibility to the infection and the severity of the disease.
With regard to viral factors, it has been shown that there is
no significant difference in the genetic sequences of
viruses causing the two major outbreaks in Hong Kong,
namely the Prince of Wales Hospital and Amoy Gardens
outbreaks, despite the significant difference in the mortal-
ity rates and diarrheal rates of the two cohorts [6]. Further-
more, several association studies have been conducted to
investigate the possible contribution of host genetic fac-
tors in the determination of the susceptibility and progno-
sis of SARS-coronavirus infection. Thus, certain human
leukocyte antigen subtypes have been shown to be more
prevalent in SARS patients [7] and in those who had
poorer outcomes [8]. On the other hand, the polymor-
phism in the angiotensin converting enzyme II gene, cod-
ing for a functional receptor of the SARS-coronavirus, is
not associated with the susceptibility or outcome of SARS
[9]. Recently, it has also been reported that the deletion of
the 287 bp Alu repeat (D allele) in intron 16 of the ACE
gene is associated with hypoxemia in SARS patients [10].
However, there are several limitations to this previous
study. First, only 44 SARS patients were studied. Second,
hypoxemia was arbitrarily defined as requiring oxygen
supplementation. Moreover, patients who died were
excluded from the study. These factors may be potential
confounders to a genetic association study.
Therefore, in this study, we investigated the association of
the ACE insertion/deletion (I/D) polymorphism of the
287 bp Alu repeat to the susceptibility to SARS and the
development of adult respiratory distress syndrome
(ARDS) with a larger population.
Methods
Study population
This study was reviewed and approved by the Ethical
Committee of the Prince of Wales Hospital, Hong Kong.
Patients who were admitted to the hospitals of the New
Territories East cluster of Hong Kong for the treatment of
SARS were recruited retrospectively. The recruitment of
patients depended on the availability of blood samples.
All patients, including survivors and deceased patients,
with available blood samples were recruited. For geneti-
cally related SARS patients, only the index case (the first
individual who developed symptoms) was recruited. All
patients were of Chinese ethnicity and fulfilled the World
Health Organisation case definition of probable SARS
[11]. Three hundred and twenty-six healthy individuals
undergoing routine health check were recruited as con-
trols. The control subjects were recruited before the SARS
epidemic and none of them had respiratory symptoms.
All control subjects were ethnical Chinese and were not
genetically related.
Definition of adult respiratory distress syndrome (ARDS) 
and patients with severe disease
The association between genotype and disease outcome
was studied in the SARS patients. Two categories of
patients were considered as having a severe disease: (1)
patients who developed ARDS; and (2) patients who
required admission to the intensive care unit (ICU). A
patient was classified as having ARDS if he or she fulfilled
all criteria of the joint American/European Consensus for
ARDS [12], including: (1) acute onset of respiratory dis-
tress; (2) presence of bilateral infiltrates on chest X-ray;
(3) having a ratio of arterial partial pressure of oxygen to
inspired fractional oxygen concentration (PaO2/FiO2) of
less than 26.8 kPa and absence of clinical evidence of left
heart failure.
ACE Genotyping
DNA was extracted from whole blood using a QIAamp
DNA Blood Mini Kit (Qiagen) with the 'Blood and Body
Fluid Spin protocol' as recommended by the manufac-
turer. ACE I/D genotypes were determined by polymerase
chain reaction amplification. The forward and reverse
primers were 5'-CTGGAGACCACTCCCATCCTTTCT-3'
and 5'-GATGTGGCCATCACATTCGTCAGAT-3', respec-
tively. Reactions were set up in a volume of 25 µl contain-
ing 0.1 µM of each primer, 1X buffer II (Applied
Biosystems), 2 mM MgCl2, 0.2 mM of each dNTP, 1.25 U
Taq polymerase (AmpliTaq Gold DNA polymerase,
Applied Biosystems) and 20 ng DNA. After initial denatur-
ation at 95°C for 12 min, the reaction mixtures were sub-
jected to 40 cycles of 94°C for 1 min, 58°C for 1 min and
72°C for 1 min, and a final extension at 72°C for 5 min.
This method yielded amplification products of 480 bp for
the I allele and 192 bp for the D allele. The products were
electrophoresed and visualized in 2% agarose gels with
ethidium bromide.
Statistical analysis
Statistical analyses were performed using SigmaStat, Ver.
3.0; SPSS. Disease associations were compared by chi-
square tests. Univariate and multivariate logistic regres-
sion analyses were performed to identify predictors of
ARDS or the outcome of SARS.BMC Infectious Diseases 2005, 5:26 http://www.biomedcentral.com/1471-2334/5/26
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Table 1: Demographic data of SARS patients. The patients are categorized by the development of ARDS (ARDS vs non-ARDS). All 
patients who had developed ARDS required intensive care. The numbers listed in the table represent the number of patients (except 
the numbers list in the first row which signify age).
ARDS non-ARDS
Age mean (range) 59.1 years (24–83) 36.9 years (21–76)
M:F 9/8 58/65
Smoking 2 5
HbsAg positive 0 7
Comorbidities
chronic obstructive pulmonary disease 0 3
Ischemic heart disease 5 2
Cerebral vascular disease 3 4
Cancer 0 2
Diabetes mellitus 1 6
Chronic renal disease 0 1
Liver cirrhosis 0 1
Table 2: Genotypic and allelic frequencies of ACE I/D polymorphism in SARS patients and control subjects
SARS cases Controls
n = 140 n = 326
Genotypic frequency
DD 15 (11%) 43 (13%)
ID 65 (46%) 133 (41%)
II 60 (43%) 150 (46%)
χ 2 value = 1.43, df = 2, p = 0.489
Allelic frequency
D 95 (34%) 219 (34%)
I 185 (66%) 433 (66%)
χ 2 value = 0.000624, df = 1, p = 0.980
Table 3a: Genotypic and allelic frequencies of ACE I/D polymorphism in SARS patients who had developed or had not developed 
ARDS
ARDS Non-ARDS
n = 17 n = 123
Genotypic frequency
DD 2 (12%) 13 (10%)
ID 4 (23%) 61 (50%)
II 11 (65%) 49 (40%)
χ 2 value = 4.361, df = 2, p = 0.113
Allelic frequency
D 8 (24%) 87 (35%)
I 26 (76%) 159 (65%)
χ 2 value = 1.376, df = 1, p = 0.241BMC Infectious Diseases 2005, 5:26 http://www.biomedcentral.com/1471-2334/5/26
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Results
Demographics
One hundred and forty SARS patients (67 males, 73
females) and 326 healthy individuals (172 males, 154
females) were recruited. The mean ages of the SARS
patients and control subjects were 39.9 and 42.5 years,
respectively (p = 0.93). Seventeen of the 140 SARS patients
developed ARDS during the course of their illness. The
demographic data of the SARS patients who had or had
not developed ARDS are summarized in table 1. Patients
who developed ARDS were significantly older than those
who did not develop ARDS (p < 0.001). There was no sig-
nificant difference in gender, smoking habits, hepatitis B
status and the presence of comorbidity between the two
groups. Thirty-five patients required intensive care and
sixteen died. Patients who required intensive care were
significantly older than those with milder disease.
Genotypic and allelic frequencies of ACE I/D 
polymorphism
The genotypic distributions and allelic frequencies of ACE
I/D polymorphism in the SARS patients and control sub-
jects are shown in table 2. The genotypic distributions of
the SARS patients and the healthy control subjects follow
the Hardy-Weinberg equilibrium using chi-square analy-
sis. There was no significant difference in the genotypic
distributions (χ 2 value = 1.43, df = 2, p = 0.489) and allelic
frequencies (χ 2 value = 0.000624, df = 1, p = 0.980) of the
two groups. Among the SARS patients, we further
analyzed the genotypic distributions and allelic
frequencies of ACE I/D polymorphism in patients who
developed ARDS and in those who did not develop ARDS
in the course of their illness. The results are shown in table
3a. There was no significant difference in the genotypic
distributions (χ 2 value = 4.361, df = 2, p = 0.113) and
allelic frequencies (χ 2 value = 1.376, df = 1, p = 0.241)
between the two groups. Besides, there was also no signif-
icant difference in the genotypic distributions (χ 2 value =
2.489, df = 2, p = 0.288) and allelic frequencies (χ 2 value
= 1.424, df = 1, p = 0.233) between patients who did or
did not require intensive care. The results are shown in
table 3b.
Logistic regression on the development of ARDS or 
requirement of intensive care
In the univariate analysis, we did not detect any signifi-
cant difference in the number of D alleles in the ACE pol-
ymorphism between patients who did and did not
develop ARDS (p = 0.169, OR = 0.549 (95% CI: 0.23–
1.29). Following multivariate logistic regression analysis,
age was found to be the only significant factor that deter-
mined the development of ARDS in SARS patients (table
4a). In the multivariate analysis for the requirement of
intensive care, we have shown that age and male sex are
associated with the requirement of intensive care (table
4b).
Discussion
The possible contribution of host genetic factors to the
susceptibility and outcome of SARS-coronavirus infection
has been investigated through several association studies
[7-10]. In contrast to a recent report showing an associa-
tion between the presence of the D allele of the ACE gene
and hypoxemia in SARS patients [10], we have shown that
the I/D polymorphism of the ACE gene is associated with
neither increased susceptibility to SARS-coronavirus infec-
tion nor progression to ARDS once infected. In multivari-
ate logistic regression analysis, we have identified that age
is the only significant factor associated with the develop-
ment of ARDS while age and male sex are independently
associated with the requirement of intensive care in SARS
Table 3b: Genotypic and allelic frequencies of ACE I/D polymorphism in SARS patients who had or had not required intensive care 
(ICU vs non-ICU)
ICU Non-ICU
n = 35 n = 105
Genotypic frequency
DD 3 (9%) 12 (11%)
ID 13 (37%) 52 (50%)
II 19 (54%) 41 (39%)
χ 2 value = 2.489, df = 2, p = 0.288
Allelic frequency
D 19 (27%) 76 (36%)
I 51 (73%) 134 (64%)
χ 2 value = 1.424, df = 1, p = 0.233BMC Infectious Diseases 2005, 5:26 http://www.biomedcentral.com/1471-2334/5/26
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patients. Our findings are consistent with other published
reports [2,3].
There are several possible explanations for the discrepan-
cies in our conclusion and that by Itoyama et al [10] con-
cerning the association between ACE polymorphism and
the outcome of SARS. First, the inclusion of subjects
within the same family and exclusion of deceased patients
by the previous study might cause potential bias, espe-
cially when the frequency of the DD genotype was
reported to be as low as 6% in control subjects [10]. In this
study, we have only included the index patient if more
than one member in a family developed SARS. Second, we
have used a well defined endpoint of ARDS instead of the
requirement of supplemental oxygen. SARS infection
commonly leads to respiratory distress and over 80% of
patients were given supplemental oxygen during the
course of their illness in our cohort. Therefore, it seems to
be more appropriate to use ARDS instead of the require-
ment of oxygen supplement to define the severity of SARS.
As ARDS is the more severe end of the spectrum of disease
progression, any potential association between genotype
and disease progression would become even more obvi-
ous when the most severe cases were considered. Simi-
larly, the disease outcome was not associated with ACE I/
D genotype when we also used another broader definition
for severe disease after SARS infection (requiring intensive
care or death).
Previous studies on Caucasian populations have sug-
gested that the presence of the D allele of the ACE gene is
associated with increased incidence of ARDS [13]. This
effect has been postulated to be related to the higher
enzyme activity in individuals with DD genotype [15].
However, it is unclear whether these observations can also
be seen in Chinese as the frequencies of DD genotype and
D allele of the ACE gene are much lower in Chinese than
in Caucasian subjects [13,16]. Furthermore, the SARS-
coronavirus characteristically affects the pneumocytes,
and the formation of multinucleated pneumocytes and
intrabronchial fibrogranulation (bronchiolitis obliterans
organizing pneumonia-like lesions) are commonly
observed in the lung biopsies of SARS patients in addition
to the typical pathological changes of ARDS [17]. There-
fore, it is possible that the pathogenesis and genetic
factors predisposing to SARS-related ARDS may be differ-
ent from ARDS resulted from other respiratory illnesses.
Previous reports have highlighted the inconsistency of the
results of genetic association studies for complex diseases
[18,19]. This inconsistency may be attributable to the dif-
ference in the genetic composition of the studied popula-
tion and study design. Here, we showed that both
Table 4a: Logistic regression on the development of ARDS in SARS patients
Variables Univariate analysis Multivariate analysis
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
ACE (no. of D allele) 0.64 (0.28 – 1.47) 0.30 0.74 (0.27 – 1.98) 0.46
Age 1.08 (1.04 – 1.12) <0.01 1.10 (1.04 – 1.16) <0.01
Male sex 1.26 (0.46 – 3.48) 0.65 0.22 (0.04 – 1.10) 0.06
Smoking 3.15 (0.56 – 17.67) 0.19 1.03 (0.11 – 9.65) 0.98
HbsAg 1 (0 – ∞ ) 0.99 1 (0.00 – ∞ ) 0.99
Co-morbidities 6.15 (2.11 – 17.96) <0.01 1.61 (0.36 – 7.26) 0.53
Table 4b: Logistic regression on the requirement of intensive care in SARS patients
Variables Univariate analysis Multivariate analysis
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
ACE (no. of D allele) 0.69 (0.38 – 1.27) 0.23 0.77 (0.39 – 1.51) 0.46
Age 1.06 (1.03 – 1.08) <0.01 1.06 (1.02 – 1.09) <0.01
Male sex 4.50 (1.92 – 10.58) <0.01 3.20 (1.25 – 8.19) 0.02
Smoking 2.37 (0.50 – 11.14) 0.28 0.68 (0.10 – 4.52) 0.69
HbsAg 2.37 (0.50 – 11.14) 0.28 2.73 (0.52 – 14.43) 0.24
Co-morbidities 6.15 (2.11 – 17.96) <0.01 1.61 (0.36 – 7.26) 0.53BMC Infectious Diseases 2005, 5:26 http://www.biomedcentral.com/1471-2334/5/26
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susceptibility and disease outcome of SARS infection were
not associated with ACE I/D polymorphism among Chi-
nese patients in contrast to the recent report studying Viet-
namese patients [10]. The sample size was definitively
larger in our study. Two different better-defined criteria
were used as indicators of severe disease progression, yet
no association was found between disease severity and
ACE I/D genotype. The D allele which was the hypotheti-
cal high risk allele [13], did not show any sign of over-rep-
resentation in the subgroups of patients with severe
disease.
Conclusion
Our analysis indicates that ACE I/D polymorphism is not
directly related to poor outcomes after SARS-coronavirus
infection in Chinese.
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